MiniMed Group, Inc.

MiniMed Group, Inc. is a global medical technology company that develops, manufactures, and markets solutions for diabetes management. The company has been in operation for over 40 years, focusing on innovation to serve customers worldwide. MiniMed was the first to commercialize all components of an integrated diabetes management system. This system aims to provide a five-star customer experience through an easier and consistent user experience, seamless integration, privacy and security, optimized performance and reliability, and an industry-leading dosing algorithm based on Time In Range (TIR) outcomes from real-world data. MiniMed's products are designed to address two primary challenges for people with diabetes (PWD). First, the company believes its products deliver superior health outcomes, as measured against European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA) guidelines, by effectively and measurably improving glycemic control compared to other available treatment options and competing products. This improvement in glycemic control can help reduce long-term complications of diabetes, enhance longevity and quality of life, and lower associated costs for health systems. Second, the customer experience offered by MiniMed's products aims to reduce or substantially eliminate the burden of diabetes management for users, their families, caregivers, and healthcare professionals (HCPs). Diabetes is a chronic, life-threatening disease affecting insulin production and response, impacting 589 million PWD globally according to the 2025 International Diabetes Federation (IDF) World Atlas.